Sixteen nonamers predicted from the results of positional scanning synthetic combinatorial library screen
Position . | . | P1 . | P2 . | P3 . | P4 . | P5 . | P6 . | P7 . | P8 . | P9 . | . |
---|---|---|---|---|---|---|---|---|---|---|---|
Amino acid . | . | Y . | L . | L . | P . | M . | V . | V . | S . | V . | . |
. | . | . | . | . | W . | Y . | . | T . | P . | . | . |
Peptide name . | Peptide sequence . | Concentration, nM . | |||||||||
44 | H- | Y | L | L | P | M | V | V | S | V | 0.00005 |
46 | H- | Y | L | L | P | M | V | T | S | V | 0.0005 |
54 | H- | Y | L | L | W | M | V | T | S | V | 0.5 |
56 | H- | Y | L | L | W | Y | V | V | S | V | 50 |
47 | H- | Y | L | L | P | M | V | T | P | V | 500 |
52 | H- | Y | L | L | W | M | V | V | S | V | 500 |
53 | H- | Y | L | L | W | M | V | V | P | V | 500 |
55 | H- | Y | L | L | W | M | V | T | P | V | 500 |
58 | H- | Y | L | L | W | Y | V | T | S | V | 500 |
45 | H- | Y | L | L | P | M | V | V | P | V | > 500 |
48 | H- | Y | L | L | P | Y | V | V | S | V | > 500 |
49 | H- | Y | L | L | P | Y | V | V | P | V | > 500 |
50 | H- | Y | L | L | P | Y | V | T | S | V | > 500 |
51 | H- | Y | L | L | P | Y | V | T | P | V | > 500 |
57 | H- | Y | L | L | W | Y | V | V | P | V | > 500 |
59 | H- | Y | L | L | W | Y | V | T | P | V | > 500 |
pp65495-503 | H- | N | L | V | P | M | V | A | T | V | 0.5 |
pp65495-503 | H- | N | L | V | P | M | V | A | T | V | 0.5 |
Position . | . | P1 . | P2 . | P3 . | P4 . | P5 . | P6 . | P7 . | P8 . | P9 . | . |
---|---|---|---|---|---|---|---|---|---|---|---|
Amino acid . | . | Y . | L . | L . | P . | M . | V . | V . | S . | V . | . |
. | . | . | . | . | W . | Y . | . | T . | P . | . | . |
Peptide name . | Peptide sequence . | Concentration, nM . | |||||||||
44 | H- | Y | L | L | P | M | V | V | S | V | 0.00005 |
46 | H- | Y | L | L | P | M | V | T | S | V | 0.0005 |
54 | H- | Y | L | L | W | M | V | T | S | V | 0.5 |
56 | H- | Y | L | L | W | Y | V | V | S | V | 50 |
47 | H- | Y | L | L | P | M | V | T | P | V | 500 |
52 | H- | Y | L | L | W | M | V | V | S | V | 500 |
53 | H- | Y | L | L | W | M | V | V | P | V | 500 |
55 | H- | Y | L | L | W | M | V | T | P | V | 500 |
58 | H- | Y | L | L | W | Y | V | T | S | V | 500 |
45 | H- | Y | L | L | P | M | V | V | P | V | > 500 |
48 | H- | Y | L | L | P | Y | V | V | S | V | > 500 |
49 | H- | Y | L | L | P | Y | V | V | P | V | > 500 |
50 | H- | Y | L | L | P | Y | V | T | S | V | > 500 |
51 | H- | Y | L | L | P | Y | V | T | P | V | > 500 |
57 | H- | Y | L | L | W | Y | V | V | P | V | > 500 |
59 | H- | Y | L | L | W | Y | V | T | P | V | > 500 |
pp65495-503 | H- | N | L | V | P | M | V | A | T | V | 0.5 |
pp65495-503 | H- | N | L | V | P | M | V | A | T | V | 0.5 |
Nonamer peptides with the substitutions as shown at each position were synthesized as described in “Materials and methods.” Substitutions predicted by the library screen of TCC 3-3F4 are shown on top of the table, immediately below each residue P of the CTL epitope, and the native sequence of the pp65495-503 CTL epitope is shown at the bottom of the table. Results of CRA are shown using peptide-sensitized HLA-A
0201–restricted EBVLCLs as target cells and TCC 3-3F4 effectors at an E/T ratio of 5. The terminus for each peptide and for pp65495-503 is −NH2, and the terminus for pp65495-503 is −OH. The concentration of peptide, in which specific killing was between 15% and 30%, represents the average results from at least 3 independent experiments carried out on different days using different batches of TCC-3F4. Peptides were tested using 10-fold dilutions ranging from 500-0.00005 nM.
CTL indicates cytotoxic T-lymphocyte; CRA, chromium release assay; EBVLCLs, Epstein-Barr virus–transformed B cell lines; E/T, effector-to-target; for other abbreviations, see Table 1.